Search results for "aids"

showing 10 items of 232 documents

Capacity assessment for provision of quality sexual reproductive health and HIV-integrated services in Karamoja, Uganda

2020

Introduction: Sexual and reproductive health (SRH) and Human Immunodeficiency Virus (HIV) are crucial global health issues. Uganda continues to sustain a huge burden of HIV and AIDS.
 Methods: A cross-sectional health facility-based assessment was performed in November and December 2016 in Karamoja Region, northern Uganda. All the 126 health facilities (HFs) in Karamoja, including 5 hospitals and 121 Health Centers (HCs), covering 51 sub-counties of the 7 districts were assessed. We assessed the capacity of a) leadership and governance, b) human resource, c) service delivery, d) SRH and HIV service integration and e) users satisfaction and perceptions.
 Results: 64% of the establi…

AdultCapacity BuildingAdolescentService delivery framework030231 tropical medicineStaffingHIV InfectionsSettore MED/42 - Igiene Generale E ApplicataYoung Adult03 medical and health sciences0302 clinical medicineAcquired immunodeficiency syndrome (AIDS)Health facilitySurveys and QuestionnairesEnvironmental healthGlobal healthHumansMedicineUgandaHIV-Integrated ServicesHuman resourcesReproductive healthService (business)Delivery of Health Care Integratedbusiness.industryArticlesGeneral MedicineMiddle Agedmedicine.diseaseQuality Sexual Reproductive HealthQuality Sexual Reproductive Health HIV-Integrated Services Karamoja UgandaCross-Sectional StudiesReproductive HealthSocioeconomic FactorsFemaleReproductive Health ServicesHealth FacilitiesSexual HealthbusinessKaramoja
researchProduct

Autoeficacia en la prevención sexual del Sida: la influencia del género

2013

Title: Self-efficacy in AIDS sexual prevention: influence of gender. Abstract: The scientific literature suggests that a low self-efficacy for con- dom use may be related to many risky behaviors for HIV transmission in young people. We analyze the self-efficacy of condom use among youth, the existence of gender differences and the relationship with other relevant variables in HIV prevention. The "Self-Efficacy Condom Use Subscale", included in the AIDS Prevention Questionnaire (Ballester, Gil and Gimenez, 2007), was administrated to 3540 university students (50.9% women, 49.1% men). The results showed that the sample obtained medi- um-high scores on self-efficacy, showing the lowest scores …

Uso preservativoPrevención sidalcsh:BF1-990Human immunodeficiency virus (HIV)Autoeficaciamedicine.disease_causemedicine.diseaseJóveneslaw.inventionPrevención SIDAlcsh:PsychologyAcquired immunodeficiency syndrome (AIDS)CondomlawmedicinePreventive interventionUso PreservativoGéneroPsychologyHiv transmissionSocial psychologyGeneral PsychologyPreventive behaviorClinical psychology
researchProduct

Producción científica, colaboración y ámbitos de investigación en Enfermedades Infecciosas y Microbiología Clínica (2003–2007)

2010

Introduction: Collaboration is essential for biomedical research. The Carlos III Health Institute (the Spanish national public organization responsible for promoting biomedical research) has encouraged scientific collaboration by promoting Thematic Networks and Cooperative Research Centres. Scientific collaboration in Enfermedades Infecciosas y Microbiologia Clinica journal is investigated. Methods: Papers published in Enfermedades Infecciosas y Microbiologia Clinica in the period 2002-2007 have been identified. Bibliometrics and Social Network Analysis methods have been carried out in order to quantify and characterise scientific collaboration and research areas. Results: A total of 805 pa…

Microbiology (medical)GerontologyPublic organizationResearch groupsbusiness.industryResearch areasCooperative researchHuman immunodeficiency virus (HIV)Library scienceBibliometricsmedicine.diseasemedicine.disease_causeAcquired immunodeficiency syndrome (AIDS)MedicinebusinessCitationEnfermedades Infecciosas y Microbiología Clínica
researchProduct

Behavioral and clinical characteristics of people receiving medical care for HIV infection in an outpatient facility in Sicily, Italy

2016

Paola Di Carlo,1 Giuliana Guadagnino,1 Palmira Immordino,1 Giovanni Mazzola,2 Pietro Colletti,2 Ilenia Alongi,1 Lucia Adamoli,1 Francesco Vitale,1 Alessandra Casuccio1 1Department of Sciences for Health Promotion and Mother-Child Care “G D’Alessandro”, University of Palermo, 2Department of Medicinal Clinics and Emerging Diseases, “Paolo Giaccone” Polyclinic University Hospital, Palermo, Italy Aim: The authors examined a cohort of HIV-positive outpatients at the AIDS Center of Palermo University in Italy in order to identify factors related to the frequency of their visits to the outpatient facility for health care services.Methods: Two hundr…

0301 basic medicinemedicine.medical_specialtyMultivariate analysisSettore MED/17 - Malattie Infettivehard-to-reach groups030106 microbiologyHuman immunodeficiency virus (HIV)Medicine (miscellaneous)HIV Outpatient Servicemedicine.disease_causeSettore MED/42 - Igiene Generale E Applicata03 medical and health sciences0302 clinical medicineOutpatient facilityAmbulatory careAcquired immunodeficiency syndrome (AIDS)CD4+ T-cell countHealth careMedicine030212 general & internal medicinePharmacology Toxicology and Pharmaceutics (miscellaneous)Access to care; CD4+ T-cell count; Hard-to-reach groups; HIV infection; HIV outpatient service; Resource use; Social Sciences (miscellaneous); Medicine (miscellaneous); Health Policy; Pharmacology Toxicology and Pharmaceutics (miscellaneous)Original Researchaccess to carelcsh:R5-920business.industryHealth PolicyUnivariatemedicine.diseaseHIV infectionresource usePatient Preference and AdherenceEmergency medicineCohortbusinesslcsh:Medicine (General)Hard-to-reach groupSocial Sciences (miscellaneous)
researchProduct

CD4saurus Rex & HIVelociraptor vs. development of clinically useful immunological markers: a Jurassic tale of frozen evolution.

2011

Abstract One of the most neglected areas of everyday clinical practice for HIV physicians is unexpectedly represented by CD4 T cell counts when used as an aid to clinical decisions. All who care for HIV patients believe that CD4+ T cell counts are a reliable method to evaluate a patient immune status. There is however a fatalistic acceptance that besides its general usefulness, CD4+ T cell counts have relevant clincal and immunological limits. Shortcomings of CD4 counts appear in certain clinical scenarios including identification of immunological nonresponders, subsequent development of cancer on antiretroviral teatment, failure on tretment simplification. Historical and recently described…

medicine.medical_specialtyT cellantiviral treatmentHuman immunodeficiency virus (HIV)lcsh:MedicineHIV; AIDS; CD4Diseasemedicine.disease_causeGeneral Biochemistry Genetics and Molecular BiologyCD4+T cellsImmune systemAcquired immunodeficiency syndrome (AIDS)medicineIntensive care medicineMedicine(all)clinical trialsImmune statusBiochemistry Genetics and Molecular Biology(all)business.industrylcsh:RCancerimmune reconstitutionGeneral Medicinemedicine.diseaseClinical trialmedicine.anatomical_structureImmunologyCommentarybusiness
researchProduct

Aids in sicily: Prevalence of antibodies to human immunodeficiency virus (HIV) in low and high risk groups

1987

A seroepidemiological survey, carried out to evaluate the prevalence of antibodies to HIV in patients with ARC and in healthy individuals at risk for AIDS, showed the infection to be widespread in the groups at risk, namely in drug abusers and hemophiliacs. However, remarkable difference existed between the prevalence of antibodies to HIV in drug abusers of the city of Palermo and those of other Sicilian provinces. Spread of the virus among Sicilian thalassemics, however, was very low and quite similar in all geographic areas. Antibodies were found very rarely (0.06%) in unpaid voluntary blood donors. The spread of the virus is still confined in high risk groups, and the major part of the s…

AdultMalemedicine.medical_specialtyAdolescentEpidemiologyDrug abuserHuman immunodeficiency virus (HIV)HIV AntibodiesAntibodies Viralmedicine.disease_causeVirusRisk groupsAcquired immunodeficiency syndrome (AIDS)AIDS-Related ComplexRisk FactorsEnvironmental healthEpidemiologymedicineHumansSicilyAcquired Immunodeficiency Syndromebiologybusiness.industryPublic healthHIVmedicine.diseaseVirologyCross-Sectional Studiesbiology.proteinFemaleAntibodybusinessEuropean Journal of Epidemiology
researchProduct

Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease in…

2011

Abstract Background Data regarding CD4+ recovery after switching from protease inhibitor (PI)-based regimens to regimens not containing PI are scarce. Methods Subjects with virological success on first-PI-regimens who switched to NNRTI therapy (NNRTI group) or to nucleoside reverse transcriptase (NRTI)-only (NRTI group) were studied. The effect of the switch on the ongoing CD4+ trend was assessed by two-phase linear regression (TPLR), allowing us to evaluate whether a change in the CD4+ trend (hinge) occurred and the time of its occurrence. Furthermore, we described the evolution of the frequencies in CD4-count classes across four relevant time-points (baseline, before and immediately after…

AdultCD4-Positive T-LymphocytesMalemedicine.medical_treatmentProtease InhibitorHuman immunodeficiency virus (HIV)CD4+ T-cellHIV InfectionsBiologymedicine.disease_causeSettore MED/17 - MALATTIE INFETTIVENucleoside Reverse Transcriptase InhibitorTimelcsh:Infectious and parasitic diseasesZidovudineRetrospective Studieimmune system diseasesAntiretroviral Therapy Highly ActivemedicineHumansProtease inhibitor (pharmacology)HIV InfectionProtease Inhibitorslcsh:RC109-216Retrospective StudiesHIV; CD4+ T-cellProteaseCd4 t cellDrug SubstitutionBackground dataHIVvirus diseasesMiddle AgedVirologyHIV; AIDS; CD4; NRTIReverse Transcriptase InhibitorCD4 Lymphocyte CountInfectious DiseasesCD4-Positive T-LymphocyteReverse Transcriptase InhibitorsRitonavirFemaleAdult; Antiretroviral Therapy Highly Active; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Female; HIV Infections; Humans; Male; Middle Aged; Protease Inhibitors; Retrospective Studies; Reverse Transcriptase Inhibitors; Time; Drug Substitution; Infectious Diseasesmedicine.drugHumanResearch Article
researchProduct

Oral leishmaniasis in an HIV-infected patient.

2000

As in most countries in the Mediterranean basin, leishmaniasis is endemic in Italy, where it has visceral (VL) and cutaneous (CL) forms caused by viscerotropic and dermotropic strains of Leishmania infantum, respectively. With the spread of the acquired immunodeficiency syndrome (AIDS) epidemic, the number of coinfections with Leishmania and human immunodeficiency virus (HIV) is increasing. Between 35% and 50% of the adult VL cases diagnosed annually in Sicily from 1991 to 1995 were related to HIV [1]; although cases of coinfection have been reported in 28 countries worldwide, the majority of these cases (1440 from 1990 to 1998) have been notified in four countries (Spain, Italy, France, Po…

Microbiology (medical)AdultLeishmaniasis MucocutaneousMaleHIV InfectionsAcquired immunodeficiency syndrome (AIDS)medicineHumansSidaLeishmaniasisbiologyLamivudineLeishmaniasisGeneral MedicineMiddle Agedmedicine.diseasebiology.organism_classificationLeishmaniaVirologyInfectious DiseasesImmunologyCoinfectionFemaleViral diseaseLeishmania infantumMouth Diseasesmedicine.drugEuropean journal of clinical microbiologyinfectious diseases : official publication of the European Society of Clinical Microbiology
researchProduct

AIDS knowledge and homophobia among French and American university students.

1990

22 male American and 24 male French college students' knowledge of AIDS scores were equivalent on a currently constructed 18-item questionnaire. Both groups answered more than 75% of the questions correctly. The American students' homophobic bias and reaction scores were higher than those of the French students on a 43-item homophobic questionnaire. The latter findings were interpreted as consistent with reduced effects of conservative, orthodox religion in France and the stability of traditional religious influence in America over the past three decades. No relation was found between knowledge of AIDS and homophobia in these small conveniently available samples.

AdultCross-Cultural ComparisonMalemedia_common.quotation_subject050109 social psychology03 medical and health sciences0302 clinical medicineAcquired immunodeficiency syndrome (AIDS)medicineHumans0501 psychology and cognitive sciencesHomosexualityRelation (history of concept)Health EducationGeneral Psychologymedia_commonAcquired Immunodeficiency Syndrome05 social sciencesSocial environmentHomosexualitymedicine.diseaseUnited States030227 psychiatryPhobic DisordersFrancePsychologySocial psychologyAttitude to HealthPsychological reports
researchProduct

Relationship Between Human Leucocyte Antigen Class I and Class II and Chronic Idiopathic Urticaria Associated With Aspirin and/or NSAIDs Hypersensiti…

2006

Background. HLA genes play a role in the predisposition of several diseases. The aim was to analyze the prevalence of HLA class I phenotypes and HLA-DRB1*genotype in patients with CIU associated with ASA and NSAIDs hypersensitivity (AICU).Methods. 69 patients with AICU, and 200 healthy subjects.Results. Subjects with HLA-B44 and HLA-Cw5 antigens were more represented in patients with AICU than in control group. Subjects with HLA-A11, HLA-B13, HLACw4, and HLA-Cw7 antigen were more represented in control group than in patients with AICU. Multiple logistic regression demonstrated an association of HLA-Cw4 and HLA-Cw7 with a lower risk of AICU, whereas carriers of HLA-B44 phenotype had a higher…

AdultMaleSettore MED/09 - Medicina InternaChronic Idiopathic UrticariaGenotypeUrticariahuman leucocyte antigen class IImmunologyGenes MHC Class IIAnti-Inflammatory AgentsHuman leukocyte antigenLower riskDrug HypersensitivityResearch CommunicationAntigenGene FrequencyRisk FactorsGenotypelcsh:PathologyMedicineHumansAlleleAllele frequencyAllelesAspirinAspirinbusiness.industryAnti-Inflammatory Agents Non-SteroidalHistocompatibility Antigens Class ICase-control studyCell BiologyHLA-DR AntigensMiddle AgedNSAIDhuman leucocyte antigen class I; human leucocyte antigen class II; chronic idiopathic urticaria; aspirin; NSAIDs; hypersensitivityhuman leucocyte antigen class IIMHC Class IIPhenotypeGenesCase-Control StudiesImmunologyFemalehypersensitivityNon-Steroidalbusinesslcsh:RB1-214medicine.drugHLA-DRB1 ChainsMediators of Inflammation
researchProduct